Rubius

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Rubius and buy or sell other stocks, ETFs, and their options commission-free!

About RUBY

Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. 

CEO
Dannielle Appelhans, MBA
CEODannielle Appelhans, MBA
Employees
Employees
Headquarters
Foxborough, Massachusetts
HeadquartersFoxborough, Massachusetts
Founded
2013
Founded2013
Employees
Employees

RUBY Key Statistics

Market cap
5.15M
Market cap5.15M
Price-Earnings ratio
-0.03
Price-Earnings ratio-0.03
Dividend yield
Dividend yield
Average volume
390.56K
Average volume390.56K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.3763
52 Week high$0.3763
52 Week low
$0.0032
52 Week low$0.0032

Stock Snapshot

Rubius(RUBY) stock is priced at $0.06, giving the company a market capitalization of 5.15M. It carries a P/E multiple of -0.03.

During the trading day, Rubius(RUBY) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading volume for Rubius(RUBY) stock has reached 0, versus its average volume of 390.56K.

The stock's 52-week range extends from a low of $0.00 to a high of $0.38.

The stock's 52-week range extends from a low of $0.00 to a high of $0.38.

People also own

Based on the portfolios of people who own RUBY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.